The Meaning Behind Value Stocks
A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labelled as a value stock.
The following stocks are considered to be notable value stocks in the healthcare sector:
- Iterum Therapeutics (NASDAQ:ITRM) - P/E: 1.13
- Viracta Therapeutics (NASDAQ:VIRX) - P/E: 2.89
- Achilles Therapeutics (NASDAQ:ACHL) - P/E: 0.51
- CVRx (NASDAQ:CVRX) - P/E: 0.14
- Cross Country Healthcare (NASDAQ:CCRN) - P/E: 4.23
Iterum Therapeutics saw a decrease in earnings per share from -0.02 in Q4 to $-0.03 now. Viracta Therapeutics has reported Q1 earnings per share at $-0.28, which has increased by 9.68% compared to Q4, which was -0.31. Achilles Therapeutics has been featured as a value stock. Achilles Therapeutics's Q1 EPS sits at $-0.45, which has not changed since last quarter (Q4). CVRx saw a decrease in earnings per share from -0.49 in Q1 to $-0.54 now. Cross Country Healthcare saw a decrease in earnings per share from 1.7 in Q1 to $1.4 now.
These 5 value stocks were selected by Benzinga Insights based on quantified analysis. While this methodical judgment process is not meant to make final decisions, our technology can give investors additional perception into the sector.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
